Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Mar:35:51-54.
doi: 10.1016/j.preghy.2023.12.006. Epub 2024 Jan 4.

Persistent postpartum hypertension 3 months post-delivery among women with hypertensive disorders of pregnancy in Tanzania: A multicenter cohort study

Alawiya A Ahmed  1 , Megan A Willkens  2 , Dismas Matovelo  1 , Richard Kiritta  1 , Godfrey Kaizilege  1 , Jyoti Mathad  2 , Robert N Peck  3
Affiliations
Observational Study

Persistent postpartum hypertension 3 months post-delivery among women with hypertensive disorders of pregnancy in Tanzania: A multicenter cohort study

Alawiya A Ahmed et al. Pregnancy Hypertens. 2024 Mar.

Abstract

Postpartum care of hypertensive disorders of pregnancy (HDP) often extends only 6 weeks after delivery in low-income countries. This multicenter observational cohort study was conducted to determine 3-month postpartum outcomes of HDP in Tanzania. Of 309 consecutive women admitted to 3 public hospitals, five (1.7 %) died within 3 months. Of the remaining 304, 292 (94.5 %) returned for 3-month follow-up visit and 41.1 % (95 % CI: 35.6 %-46.9 %) had persistent postpartum hypertension. The strongest independent predictor of hypertension persistence was reduced eGFR at delivery (aOR = 2.1[1.01,4.4]). Postpartum follow-up should routinely be extended to 3 months in all women with HDP to diagnose hypertension and prevent cardiovascular disease.

Keywords: Hypertension; Hypertensive disorders of pregnancy; Kidney disease; Mortality; Postpartum; Pregnancy.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1:
Figure 1:. Outcomes and primary findings for 309 participants
Figure 1 represents the outcomes and primary findings for 309 participants enrolled in this study.
See this image and copyright information in PMC

References

    1. Poon LC, Nguyen-Hoang L, Smith GN, Bergman L, O’Brien P, Hod M, et al. Hypertensive disorders of pregnancy and long-term cardiovascular health: FIGO Best Practice Advice. International Journal of Gynecology & Obstetrics 2023;160:22–34. 10.1002/ijgo.14540. - DOI - PubMed
    1. Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertension Research 2017 40:3 2016;40:213–20. 10.1038/hr.2016.126. - DOI - PubMed
    1. Ndaboine EM, Kihunrwa A, Rumanyika R, Im B, Massinde AN. Maternal and Perinatal Outcomes among Eclamptic Patients Admitted to Bugando Medical Centre, Mwanza, Tanzania. Afr J Reprod Health 2012;16:35–41. - PubMed
    1. Machano MM, Joho AA. Prevalence and risk factors associated with severe pre-eclampsia among postpartum women in Zanzibar: a cross-sectional study. BMC Public Health 2020;20:1347. 10.1186/s12889-020-09384-z. - DOI - PMC - PubMed
    1. Murray Horwitz ME, Rodriguez MI, Dissanayake M, Carmichael SL, Snowden JM. Postpartum health risks among women with hypertensive disorders of pregnancy, California 2008–2012. J Hypertens 2021;39:1009–17. 10.1097/HJH.0000000000002711. - DOI - PMC - PubMed

Publication types